MED Medifast PE ratio, current and historical analysis
- Stocks
- Consumer Cyclical
- NYSE: MED
- PE Ratio
The current PE ratio for Medifast stock as of Nov 5, 2025 is 609.0. This is calculated based on the TTM EPS of $0.02 and the stock price of $12.18 per share.
MED PE ratio history
The average historical PE ratio of Medifast for the last ten years is 39.47. The current price-to-earnings ratio of 609.0 is in line with the historical average. Analyzing the last ten years, MED's PE ratio reached its highest point in the Sep 2025 quarter at 683.5, when the price was $13.67 and the EPS was $0.02. The lowest point was recorded in the Mar 2024 quarter, when it reached 6.17 with a price of $38.32 and an EPS of $6.21.
Medifast PE ratio by year
Maximum annual increase: 1,160.05% in 2024
Maximum annual decrease: -50.34% in 2011
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 92.74 | 1,160.05% | $17.62 | $0.19 |
| 2023 | 7.36 | -18.22% | $67.22 | $9.13 |
| 2022 | 9 | -39.8% | $115.35 | $12.82 |
| 2021 | 14.95 | -33.44% | $209.43 | $14.01 |
| 2020 | 22.46 | 35.71% | $196.34 | $8.74 |
| 2019 | 16.55 | -38.18% | $109.58 | $6.62 |
| 2018 | 26.77 | -11.03% | $125.02 | $4.67 |
| 2017 | 30.09 | 9.14% | $69.81 | $2.32 |
| 2016 | 27.57 | 52.49% | $41.63 | $1.51 |
| 2015 | 18.08 | -43.96% | $30.38 | $1.68 |
| 2014 | 32.26 | 114.78% | $33.55 | $1.04 |
| 2013 | 15.02 | -33.98% | $26.13 | $1.74 |
| 2012 | 22.75 | 120.45% | $26.39 | $1.16 |
| 2011 | 10.32 | -50.34% | $13.72 | $1.33 |
| 2010 | 20.78 | -42.91% | $28.88 | $1.39 |
Medifast PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2025 | 683.5 | 1,505.21% | $13.67 | $0.02 |
| Jun 2025 | 42.58 | N/A | $14.05 | $0.33 |
| Mar 2025 | N/A | N/A | $13.48 | -$0.65 |
| Dec 2024 | 92.74 | 219.79% | $17.62 | $0.19 |
| Sep 2024 | 29 | 256.27% | $19.14 | $0.66 |
| Jun 2024 | 8.14 | 31.93% | $21.82 | $2.68 |
| Mar 2024 | 6.17 | -16.17% | $38.32 | $6.21 |
| Dec 2023 | 7.36 | 8.39% | $67.22 | $9.13 |
| Sep 2023 | 6.79 | -10.07% | $74.85 | $11.03 |
| Jun 2023 | 7.55 | -6.33% | $92.16 | $12.21 |
| Mar 2023 | 8.06 | -10.44% | $103.67 | $12.87 |
| Dec 2022 | 9 | 10.43% | $115.35 | $12.82 |
| Sep 2022 | 8.15 | -38.63% | $108.36 | $13.3 |
| Jun 2022 | 13.28 | 10.02% | $180.51 | $13.59 |
| Mar 2022 | 12.07 | -19.26% | $170.78 | $14.15 |
MED Price vs fair value
MED average PE ratio chart
Currently, MED's PE ratio is above its 3, 5 and 10-year averages.
PE comparison
With a price to earnings (P/E) of 609, MED stands higher than the Consumer Cyclical sector and the industry average. Looking at the Consumer Cyclical sector average of 19.04, Medifast's price to earnings (P/E) is 3,099% higher.
MED PE vs peers
MED's PE ratio is above its peer stocks WTW and ABEO.
| Stock name | PE ratio | Market cap |
|---|---|---|
| ABEO Abeona Therapeutics Inc | 3.95 | $214.86M |
| WTW Willis Towers Watson Plc | 15.38 | $30.85B |
| MED Medifast Inc | 590 | $129.7M |
Frequently asked questions
What is Medifast's PE ratio?
As of Nov 5, 2025, MED stock has a price to earnings ratio of 609.
What is the 3-year average PE ratio for Medifast (MED)?
Over the last 3 years, the average PE ratio for MED stock is 81.9.
What is the 5-year average PE ratio for Medifast (MED)?
Over the last 5 years, the average PE ratio for MED stock is 54.11.
What is the highest PE ratio for MED?
Over the last ten years, the quarterly PE ratio reached its highest level at 683.5 in the Sep 2025 quarter.
How does the current PE ratio for MED compare to its historical average?
The current PE ratio of MED is 1,443% higher than the 10-year historical average.
Why is Medifast's PE ratio so high?
MED's PE ratio is high because its earnings per share (EPS) is low relative to its stock price.
How is MED's PE ratio calculated (Medifast PE ratio formula)?
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Nov 5, 2025), Medifast's share price is $12.18. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2025 is $0.02. Therefore, Medifast's price to earnings ratio for today is 609. PE RATIO(609) = STOCK PRICE($12.18) / TTM EPS($0.02)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.